Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer
Nephron-sparing surgery (NSS) remains gold standard for the treatment of localised renal cell cancer (RCC), even in the case of a normal contralateral kidney.02/08/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 8, 2019 Category: Urology & Nephrology Source Type: news
Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: A retrospective single-center study
Renal cell carcinoma (RCC) is typically found in the older age group between 50 and 70 years of age. However, diagnosis of renal cancer is increasing more rapidly in patients less than 40 years if age compared to older age patients.02/06/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 6, 2019 Category: Urology & Nephrology Source Type: news
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study
Targeted therapy (TT) has improved survival for metastatic renal cell carcinoma (mRCC). However, survival is usually limited if brain metastases (BMs) develop.02/06/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 6, 2019 Category: Urology & Nephrology Source Type: news
If Someone in Your Life Just Survived Cancer, Here ’s How You Can Support Them Now
This article explains how to support a loved one after cancer treatment.02/05/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 5, 2019 Category: Urology & Nephrology Source Type: news
Newsmakers: Promotions and appointments of area executives
Gretchen Vaughan, Kidney Cancer Association, has been named chief executive officer of the nonprofit.02/04/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 4, 2019 Category: Urology & Nephrology Source Type: news
Some Cancers Are Rising in Millennials. Obesity Might Be Why
Kidney cancer had the sharpest annual increase for young Americans: 6.23% between 1995 and 2014.02/04/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - February 4, 2019 Category: Urology & Nephrology Source Type: news
First-Line TKIs Less Effective in Non-Clear-Cell Renal Cell Carcinoma
According to a study that was published in Urologic Oncology, patients with metastatic non-clear-cell renal cell carcinoma (nccRCC) have worse outcomes from first-line therapy with tyrosine kinase inhibitors (TKIs) than patients with metastatic clear-cell RCC (ccRCC).01/31/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 31, 2019 Category: Urology & Nephrology Source Type: news
Personalized Vaccine to be Tested in Patients with Kidney Cancer
Researchers at the Dana-Farber Cancer Institute are working to develop a vaccine for the treatment of renal cell cancer.01/30/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 30, 2019 Category: Urology & Nephrology Source Type: news
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
Sunitinib is administered on a rigid schedule that may not be optimal for all patients. We hypothesised that toxicity-driven dose and schedule changes would optimise drug exposure and outcome for each patient.01/29/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 29, 2019 Category: Urology & Nephrology Source Type: news
Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer
This study evaluates whether sunitinib and pazopanib treatments are associated with change in skeletal muscle area (SMA) and total lean body mass (LBM) as well as to compare their efficacies and safety profiles in patients with metastatic renal cell cancer (mRCC).01/29/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 29, 2019 Category: Urology & Nephrology Source Type: news
Personalised treatment benefits kidney cancer patients
Personalised treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk factors for worsening kidney disease, according to a new study published in the journal Radiology.01/29/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 29, 2019 Category: Urology & Nephrology Source Type: news
Obesity Factors May Increase Kidney Cancer Risk
According to recent research conducted by Spectrum Health, certain factors such as diastolic blood pressure and fasting insulin were found to be associated with renal cell carcinoma.01/28/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 28, 2019 Category: Urology & Nephrology Source Type: news
Imaging Advances in the Management of Kidney Cancer
New developments in cross-sectional imaging, including contrast-enhanced ultrasound, dual-energy computed tomography, multiparametric magnetic resonance imaging, single-photon emission computed tomography, and positron emission tomography, together with novel application of existing and novel radiotracers, have changed the landscape of renal mass characterization (ie, virtual biopsy) as well as the detection of metastatic disease, prognostication, and response assessment in patients with advanced kidney cancer.01/25/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 25, 2019 Category: Urology & Nephrology Source Type: news
Kidney Cancer Association Appoints Gretchen Vaughan as CEO
HOUSTON– January 24, 2019– Kidney Cancer Association is pleased to announce it has recently appointed Gretchen Vaughan as the nonprofit’s new CEO. Vaughan brings more than 27 years of experience in advanced fundraising, management, sales and major market business development in the healthcare and financial service industries. Vaughan has most recently worked as the senior director of philanthropic resources with The University of Texas MD Anderson Cancer Center, having been with the hospital in additional, previous roles since 2004. Her work with MD Anderson includes extensive fundraising and philant...
Source: Kidney Cancer Association - January 25, 2019 Category: Urology & Nephrology Source Type: news
